PM&R
Volume 2, Issue 8 , Pages 751-756 , August 2010

Incidence and Identification of Intrathecal Baclofen Catheter Malfunction

This information was presented as a poster presentation at the APM&R Annual Assembly in Austin, Texas, in 2009.

  • Eric M. Dvorak, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226
    • Corresponding Author InformationAddress correspondence to E.M.D.
    • ,
  • John R. McGuire, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Mary Elizabeth S. Nelson, APNP

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI

Received 22 November 2009 ,Accepted 28 January 2010.

References 

  1. Ordia JI, Fischer E, Adamski E, Spatz EL. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg. 1996;85:452–457
  2. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up. Arch Phys Med Rehabil. 1996;77:35–39
  3. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. Am J Phys Med Rehabil. 2000;79:536–541
  4. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg. 2003;39:1–6
  5. Plassat R, Perrouin Verbe B, et al. Treatment of spasticity with intrathecal baclofen administration: Long-term follow-up review of 40 patients. Spinal Cord. 2004;42:686–693
  6. Pak S, Jallo GI, Biser A, Ziessman HA. Indium-111 diethylene-triamine-pentaacetic acid scintigraphy in the evaluation of function and patency of baclofen intrathecal infusion systems. Neurosurg Focus. 2007;23(1):E17
  7. Breton FL, Daviet JC, Monteil J, et al. Radioisotopic control for baclofen pump catheter failure. Spinal Cord. 2001;39:283–285
  8. Hoving MA, Smulders NM, Abdul Fatah B, et al. The use of an Indium111 DTPA flow study in the evaluation of a lumbar swelling in a girl with a baclofen pump. Neuropediatrics. 2006;37:99–101
  9. O'Connell M, Wong TZ, Forkheim KE, Jain M, Shipes SW, Fuchs HE. Comparison of Tc99m-DTPA and Indium-111 DTPA studies of baclofen pump function. Clin Nucl Med. 2004;29:578–580
  10. Sorokin A, Annabi E, Yang WC, Kaplan R. Subdural intrathecal catheter placement: Experience with two cases. Pain Phys. 2008;11(5):677–680
  11. Pasquier Y, Cahana A, Schnider A. Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord. 2003;41:700–702
  12. Ngo K, McGuire JR. Failure to identify intrathecal baclofen pump/catheter problems can lead to unnecessary healthcare costs: A case report [abstract]. PM&R. 2009;1:S122–S123
  13. Bardutzky J, Tronnier V, Schwab S, Meinck H-M. Intrathecal baclofen for stiff-person syndrome: Life-threatening intermittent catheter leakage. Neurology. 2003;60:1976–1978
  14. Vender JR, Hester S, Waller J, Rekito A, Lee MR. Identification and management of intrathecal baclofen pump complications: A comparison of pediatric and adult patients. J Neurosurg Pediatr. 2006;104:9–15
  15. Francisco GE, Saulino MF, Yablon SA, Turner M. Intrathecal baclofen therapy: An update. PM&R. 2009;1:852–858
  16. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg. 2003;98:291–295
  17. Barnes M. An overview of the clinical management of spasticity. In:  Barnes M,  Johnson G editor. Upper Motor Neuron Syndrome and Spasticity. 2nd ed. New York: Cambridge University Press; 2008;p. 1–8
  18. Newman LB, Arieff AJ, Wasserman RR. Present status in the management of spasticity and spasm: Preliminary report. Arch Phys Med Rehabil. 1954;35:427–436
  19. Taha J, Favre J, Janszen M, Galarza M, Taha A. Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable synchromed pumps. Neurosurgery. 2004;55:390–394
  20. Rigoli G, Terrini G, Cordioli Z. Intrathecal baclofen withdrawal syndrome caused by low residual volume in the pump reservoir: A report of 2 cases. Arch Phys Med Rehabil. 2004;85:2064–2066
  21. Li TC, Chen MH, Huang JS, Chan JY, Liu YK, Chen MH. Catheter migration after implantation of an intrathecal baclofen infusion pump for severe spasticity: A case report. Kaohsiung J Med Sci. 2008;24(9):492–497
  22. Schmidt E, Oates E. In-111 DTPA to evaluate the patency of an implanted intrathecal infusion pump. Clin Nucl Med. 1997;22(11):768–770
  23. Stinchon JF, Shah NP, Ordia J, Oates E. Scintigraphic evaluation of intrathecal infusion systems: Selection of patients for surgical or medical management. Clin Nucl Med. 2006;31:1–4
  24. Stokic DS, Yablon SA, Hayes A, Vesovic-Potic V, Olivier J. Dose-response relationship between the H-reflex and continuous intrathecal baclofen administration for management of spasticity. Clin Neurophysiol. 2006;117:1283–1289
  25. Yablon SA, Stokic DS. Neurophysiologic evaluation of spastic hypertonia: Implications for management of the patient with the intrathecal baclofen pump. Am J Phys Med Rehabil. 2004;83(suppl):S10–S18
  26. Stokic DS, Yablon SA. Neurophysiological basis and clinical applications of the H-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity. Acta Neurochir Suppl. 2007;97:231–241

PII: S1934-1482(10)00085-7

doi: 10.1016/j.pmrj.2010.01.016

PM&R
Volume 2, Issue 8 , Pages 751-756 , August 2010

Article Tools

* Image Usage & Resolution